Priser
Platform
Blog
Om os
Download
Brown-Forman Corp Registered Shs -B- Non Vtg
Brown-Forman Corp Registered Shs -B- Non Vtg
New York Stock Exchange
0

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I BROWN-FORMAN CORP REGISTERED SHS -B- NON VTG MED ENDAVU: Køb Brown-Forman Corp Registered Shs -B- Non Vtg ($BF B) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Brown-Forman Corp Registered Shs -B- Non Vtg, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Om

Wuxi Biologics (Cayman) Inc. is a major player in the biotechnology and medical research sector, specializing in providing comprehensive solutions for the discovery, development, and manufacturing of biologic drugs. As an investment holding company, it operates through two main business segments. The Biologics segment focuses on end-to-end services that encompass biologics discovery, process development, and large-scale manufacturing. Its WuXi XDC segment delivers contract research, development, and manufacturing organization (CRDMO) services, particularly for antibody-drug conjugates (ADCs) and various bioconjugates, catering to both domestic and international clientele. Headquartered in Wuxi, China, and supported by a workforce of over 12,000 employees, the company plays a critical role in advancing biologics innovation and accelerating drug development for pharmaceutical and biotechnology companies worldwide. Wuxi Biologics (Cayman) Inc.'s business model helps lower the barriers for biopharma firms to bring new therapeutic products to market by offering state-of-the-art technical expertise and integrated solutions throughout the biologics lifecycle.

Information

Ticker1FW2
Land
Kina
Antal medarbejdere12.575
Hjemmesidewuxibiologics.com
SektorSundhed
IndustriBioteknologi